All News
Completed Early RA prevention trials using agents like steroids, RTX, atorvastatin, abatacept
No sig difference in steroids, atorvastatin
RTX delayed onset but no overall diff
Abatacept decreased RA progression at 1.5 years
@RheumNow #RNL2022 https://t.co/v7WxI2P7r5
Robert B Chao, MD doctorRBC ( View Tweet)
Top Influencers of #RNL2022: @RheumNow @uptoTate @Janetbirdope @NoufAhmedAlham2 @doctorRBC @hausmannMD More 📊 https://t.co/5tIzMLfqrh
Symplur Hashtags healthhashtags ( View Tweet)
@Janetbirdope on drug cycling in #RA. What’s beyond TNFi failure? No golden rule, but:
👉🏻 switching to non-TNF can be superior than staying with the TNFi class
👉🏻 response to other bDMARs maybe blunted in non-TNFi naive
👉🏻 JAKi can be a good choice for some @RheumNow #RNL2022 https://t.co/25MiiFh2CK
Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
How NOT to get rheumatoid arthritis. Excellent tips by @karen_kc123 #RNL2022 #rheumatoidarthritis https://t.co/brLeWzioQD
Jonathan Hausmann MD hausmannMD ( View Tweet)
Patients often ask me what they can do on their part to help their disease... this is it! @karen_kc123 reviews the modifable risks in RA. @rheumnow #RNL2022 @CreakyJoints https://t.co/FM0BtNX6eb
TheDaoIndex KDAO2011 ( View Tweet)
#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR
Janet Pope Janetbirdope ( View Tweet)
Dr. Elena Myasoedova on Multimorbidities and RA
Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts
@RheumNow #RNL2022 https://t.co/N6VPdU6wzV
Robert B Chao, MD doctorRBC ( View Tweet)
Cool idea 💡 for #treatment of #multimorbidity in #rheumatoid arthritis from an interactive web platform #RNL2022 @RheumNow https://t.co/QlTWCV8s9F
Janet Pope Janetbirdope ( View Tweet)
Role of cytokines in pain ?!
Notice CNS activity disappeared immediately before TJC/SJC improvement!!
@Tuhina_Neogi @RheumNow #RNL2022 https://t.co/TXKZwepBTF
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
@Janetbirdope on drug cycling vs. switching in RA
Interesting data showing switching to non-TNFi superior to cycling in TNFi-incomplete responders
Most bDMARDs and JAKi have blunted response post-TNFi
@RheumNow #RNL2022 https://t.co/Lb3wvHZdzN
Robert B Chao, MD doctorRBC ( View Tweet)
@Janetbirdope shares her study on real world retention of JAKi vs biologics in #RA #RNL2022 @rheumnow https://t.co/hNxQ8t4LHH
TheDaoIndex KDAO2011 ( View Tweet)
Retention of JAKinibs longer than bDAMRDs in RA
Interesting but wonder how this will be affected given new FDA warnings.
@RheumNow #RNL2022 https://t.co/Gj2wBFbaAj
Robert B Chao, MD doctorRBC ( View Tweet)
Emerging pain targets!
Will start prescribing topical Capsaicin more !!
Amazing talk by @Tuhina_Neogi
@RheumNow #RNL2022 https://t.co/DjAtTjfGCo
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#ClinicalPearl #multimorbidity worsens outcomes in #rheumatoid arthritis. 50% of #RA pts has this and 2x > than age sex matched pop’n. Worse as interplay of diseases, drug disposition, med adherence, drug interactions, etc #RNL2022 @RheumNow Elena Myasoedova https://t.co/aTF0O8o0tg
Janet Pope Janetbirdope ( View Tweet)
Dr. Elena Myasoedova defines multimorbidity and its difference for comorbidities. Multimorbidity (MM) focuses on the patient, comorbidities focuses on the disease. RA pts have 2.3 X higher MM and can precede RA. #RNL2022 @rheumnow https://t.co/FE489rJnnP
TheDaoIndex KDAO2011 ( View Tweet)
Dr Elena Myasedova lectures on the problem of multimorbidity in #RA.#RNL2022 https://t.co/Ti5PZaAx2Z
Dr. John Cush RheumNow ( View Tweet)
#RNL2022 Psoriatic Disease for Rheumatologists with Drs. Gordon and Merida. https://t.co/PEj0dI7ucH
Dr. John Cush RheumNow ( View Tweet)
Learning so much this weekend at @rheumnow. Great talks this am on psoriatic disease for rheumatologists and on hot topics in rheumatology featuring adults with JIA, pain, and central sensitization in rheumatic disease. #RNL2022 https://t.co/UBbchcJu4B
Aradhna-Agarwal AradhnaAgarwal ( View Tweet)
Impact of fibromyalgia on Anti-TNF treatment response!!
Philip Mease @RheumNow #Rnl2022 https://t.co/BYdZA3uu94
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
What about fatigue in rheumatic diseases?!
Philip Mease @RheumNow #Rnl2022 https://t.co/1RbnVwDZTp
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)